Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats.

MLA

Song, Pengfei, et al. “Plasma and Cerebrospinal Fluid Pharmacokinetics of the Novel Tetrahydroisoquinoline EDL-155 in Rats.” Cancer Chemotherapy and Pharmacology, vol. 61, no. 6, May 2008, pp. 1037–44. EBSCOhost, https://doi.org/10.1007/s00280-007-0563-z.

APA

Song, P., Ma, F., Wang, F., Wang, X., Patil, R., Ramagiri, S., Orr, W. E., Miller, D. D., Geisert, E., & Yates, C. R. (2008). Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats. Cancer Chemotherapy and Pharmacology, 61(6), 1037–1044. https://doi.org/10.1007/s00280-007-0563-z

Chicago

Song, Pengfei, Fei Ma, Fan Wang, XiangDi Wang, Renukadevi Patil, Suma Ramagiri, William E Orr, Duane D Miller, Eldon Geisert, and Charles R Yates. 2008. “Plasma and Cerebrospinal Fluid Pharmacokinetics of the Novel Tetrahydroisoquinoline EDL-155 in Rats.” Cancer Chemotherapy and Pharmacology 61 (6): 1037–44. doi:10.1007/s00280-007-0563-z.